Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers

Background: Vaccines for SARS-CoV-2 have been critical for preventing disease. Previous research showed patients with diabetes have impaired immunity. This study aimed to determine the immunity to coronavirus after CoronaVac by comparing patients with type 2 diabetes (T2D) and healthcare workers (HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dechates, Bothamai, Porntharukchareon, Thachanun, Sirisreetreerux, Supamas, Therawit, Phonthip, Worawitchawong, Supanat, Sornsamdang, Gaidganok, Soonklang, Kamonwan, Tawinprai, Kriangkrai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052125/
https://www.ncbi.nlm.nih.gov/pubmed/36992267
http://dx.doi.org/10.3390/vaccines11030684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052125/
https://www.ncbi.nlm.nih.gov/pubmed/36992267
http://dx.doi.org/10.3390/vaccines11030684

Ejemplares similares